Loading...

REGN REGENERON PHARMACEUTICALS INC Dividend Policy Changes 8-K Filing

RGNR

RGN

REGENERON PHARMACEUTICALS INC

(REGN)

2025 8-K

Show Summary

Summary

Financial Statements

Financial Results

Financial Update

Q3 Earnings Report

Q3 2024 Preview

Earnings Reports

Financial Results

Shareholder Vote Results

Financial Results

Financial Results Announcement

Management Appointments

Corporate Update at Healthc...

Financial Results Announcement

Financial Results

Earnings Reports

Amendment to Bylaws and Sha...

Financial Results Announcement

Management Changes

Financial Results for Q1 2023

External Links:

Regeneron Pharmaceuticals announced its financial results for 2024, declared a quarterly cash dividend of $0.88 per share, and initiated a $3.0 billion share repurchase program.

AI Assistant

REGENERON PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.